BRIEF published on 06/04/2024 at 07:35, 1 year 7 months ago GenSight Biologics to Present at Key Medical Conferences in 2024 Gene Therapy GenSight Biologics Medical Conferences 2024 LUMEVOQ® LHON
BRIEF published on 06/04/2024 at 07:35, 1 year 7 months ago GenSight Biologics fera une présentation lors de conférences médicales clés en 2024 Thérapie Génique Produits Biologiques GenSight LUMEVOQ® Conférences Médicales 2024 NOHL
PRESS RELEASE published on 06/04/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases GenSight Biologics to present at key medical and stakeholder meetings, including 16th Meeting of the EUNOS. Papers on LUMEVOQ® for LHON to be showcased Gene Therapy GenSight Biologics Medical Conferences LUMEVOQ Retinal Neurodegenerative Diseases
PRESS RELEASE published on 06/04/2024 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués GenSight Biologics va présenter ses thérapies géniques innovantes pour les maladies neurodégénératives lors de conférences médicales et scientifiques importantes Thérapie Génique GenSight Biologics Maladies Neurodégénératives Conférences Médicales Présentations Scientifiques
BRIEF published on 06/03/2024 at 07:35, 1 year 7 months ago GenSight Biologics accueille William Monteith au Conseil d’administration Conseil D’administration Nomination GenSight Biologics Thérapies Géniques William Monteith
BRIEF published on 06/03/2024 at 07:35, 1 year 7 months ago GenSight Biologics Welcomes William Monteith to the Board of Directors Board Of Directors Nomination GenSight Biologics William Monteith Gene Therapies
PRESS RELEASE published on 06/03/2024 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués GenSight Biologics nomme William Monteith à son Conseil d'administration. Monteith apportera son expertise en fabrication de thérapies géniques pour soutenir les progrès de l'entreprise Conseil D'administration Fabrication GenSight Biologics Thérapies Géniques William Monteith
BRIEF published on 05/23/2024 at 11:40, 1 year 8 months ago Franchissement de seuils pour GENSIGHT BIOLOGICS S.A. Actions Franchissement De Seuils Bons De Souscription GenSight Biologics Armistice Capital
BRIEF published on 05/23/2024 at 11:40, 1 year 8 months ago Crossing thresholds for GENSIGHT BIOLOGICS SA Actions Crossing Thresholds GenSight Biologics Armistice Capital Subscription Warrants
PRESS RELEASE published on 05/23/2024 at 11:35, 1 year 8 months ago Franchissement de seuils Déclaration de franchissement de seuils par Armistice Capital, LLC concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Franchissement De Seuils Armistice Capital LLC GENSIGHT BIOLOGICS SA Déclaration Régularisation
Published on 02/02/2026 at 00:05, 3 hours 43 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 2 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 02:50, 57 minutes ago Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report
Published on 02/01/2026 at 20:25, 7 hours 22 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 11 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 15 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 2 days 1 hour ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 18:40, 2 days 9 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 10 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 10 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 19 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
